참고문헌
- Bang SM, Kim YR, Cho HI, Chi HS, Seo EJ, Park CJ, et al. Identification of 13q deletion, trisomy 1q and IgH rearrangement as the most frequent chromosomal changes found in Korean patients with multiple myeloma. Cancer Genetics and Cytogenetics. 2006,168:124-132. https://doi.org/10.1016/j.cancergencyto.2006.02.015
- Chang HJ, Kim JW, Kim NK, Jeon YJ. The relationship between the progression of colorectal cancer and microRNA polymorphism. Journal of Clinical Oncology. 2011,7:50-57.
- Corthals SL, Jongen-Lavrencic M, Knegt Y, Peeters JK, Beverloo HB, Lokhorst HM, et al. Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma. Leukemia Resarch. 2010,34:677-681. https://doi.org/10.1016/j.leukres.2009.10.026
- Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nature Reviews Genetics. 2009,10:704-714. https://doi.org/10.1038/nrg2634
- Farazi TA, Spitzer JI, Morozov P, Tuschi T. MicroRNAs in human cancer. Journal of Pathology. 2011,223:102-115. https://doi.org/10.1002/path.2806
- Han KH and Kim TJ. Effects of promoter methylation on the expression levels of plakoglobin Gene in both the ARO thyroid cancer cell line and cancer tissues. Korean J Clin Lab Sci . 2009,41:180-188.
- Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. American Society of Clinical Oncology. 2009,27:5848-5856. https://doi.org/10.1200/JCO.2009.24.0317
- Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, et al. Functional links between clustered microRNAs:suppression of cell cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009,37:1672-1681. https://doi.org/10.1093/nar/gkp002
- Kota J, Chivukula R, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009,137(6):1005-1017. https://doi.org/10.1016/j.cell.2009.04.021
- Lee HJ, Park CS, Deftereos G, Morihara J, Stern JE, Hawes SE, et al. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features. World Journal of Surgical Oncology. 2012,10:174-184. https://doi.org/10.1186/1477-7819-10-174
- Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, Kretzschmar AK, et al. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3- mediatde induction of microRNA-21 through a highly conserved enhancer. blood. 2007,110:1330-1333.
- Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Molecular Cancer. 2006,5:24. https://doi.org/10.1186/1476-4598-5-24
- McCarthy DJ, Smyth GK. Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics. 2009,25(6):765-771. https://doi.org/10.1093/bioinformatics/btp053
- Munker R, Calin GA. MicroRNA profiling in cancer. Clinical Science. 2011,121:141-158. https://doi.org/10.1042/CS20110005
- Pichiorri Fl, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. PNAS. 2008,105(35):12885-12890. https://doi.org/10.1073/pnas.0806202105
- Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TLJ, Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res. 2007,67(13):6130-6135. https://doi.org/10.1158/0008-5472.CAN-07-0533
- Roccaro AM, Sacco A, Thompson B, Leleu X, Azab1 AK, Azab Feda, et al. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood. 2009,26(113):6669-6680.
- Satoh JI. Molecular network analysis of human microRNA targetome: from cancers to Alzheimer's disease. Satoh BioData Mining. 2012,5(1):17. doi: 10.1186/1756-0381-5-17.
- Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008,299(4):425-436.
- Son JW, Kim YJ, Cho HM, Lee YM, Kwon SJ, Choi E, et al. MicroRNA expression Korean non-small cell lung cancer. The Korean Academy of Tuberculosis and Respriratoy Diseases. 2009,67:413-421. https://doi.org/10.4046/trd.2009.67.5.413
- Sung MH, Lee HT, Shin MS, Oh SY, Kim WY. Evaluation of p16INK4a/Ki-67 dual immunostaining in liquid-based cytology for diagnosis of uterine cervical dysplasia and cancer. Korean J Clin Lab Sci. 2015,47:132-139. https://doi.org/10.15324/kjcls.2015.47.3.132
- Takimoto M, Ogawa K, Kato Y, Saito T, Suzuki T, Irei M, et al. Close relation between 14q32/IGH translocations and chromosome 13 in abnormalities multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF. International Journal of Hematology. 2008,87(3):260-265. https://doi.org/10.1007/s12185-008-0039-x
- Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, Wang CW, et al. Expression profile of microRNAs in young stroke patients. PLoS One. 2009,4(11):e7689. https://doi.org/10.1371/journal.pone.0007689
- Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J. The role of microRNAs in normal and malignant hematopoiesis. European Journal of Haematology. 2009,84:1-16. https://doi.org/10.1002/ajh.21324
- Yaguang X, Go N, Elaine G, Chris GM, Kenji K, Kazuhiko H, et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin- embedded samples. RNA. 2007,13:1668-1674. https://doi.org/10.1261/rna.642907
피인용 문헌
- Comparison of the miR-23b and miR-203 Expressions in Endometrial Cancer vol.49, pp.4, 2017, https://doi.org/10.15324/kjcls.2017.49.4.455
- Expression of MicroRNA-221 in Korean Patients with Multiple Myeloma vol.50, pp.2, 2015, https://doi.org/10.15324/kjcls.2018.50.2.197